INTERNATIONAL PATENT: CHASE THERAPEUTICS CORPORATION FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR TREATING ANHEDONIA"

GENEVA, July 10 -- CHASE THERAPEUTICS CORPORATION (1825 K Street, N.W., Suite 520Washington, District of Columbia 20006) filed a patent application (PCT/US2024/062080) for "COMPOSITIONS AND METHODS FOR TREATING ANHEDONIA" on Dec 27, 2024. With publication no. WO/2025/145022, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHASE, Thomas N. (c/o CHASE THERAPEUTICS CORPORATION1825 K Street, N.W., Suite 520Washington, District of Columbia 20006), CLARENCE-SMITH, Kathleen E. (c/o CHASE THERAPEUTICS CORPORATION1825 K Street, N....